phorbolol myristate acetate has been researched along with Experimental Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ibrahim, S; Levin, B; Meruelo, D; Pellicer, A; Suzme, R; Tseng, JC | 1 |
| Maté, U; Melchionne, S; Segal, A; Seidman, I; Smith, A; Solomon, JJ; Van Duuren, BL | 1 |
2 other study(ies) available for phorbolol myristate acetate and Experimental Neoplasms
| Article | Year |
|---|---|
Sindbis viral vectors target hematopoietic malignant cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Female; Gene Expression Regulation, Neoplastic; Genetic Therapy; Genetic Vectors; Hematologic Neoplasms; Humans; Injections, Intraperitoneal; Jurkat Cells; Male; Mice; Mice, Inbred AKR; Mice, Inbred C3H; Mice, Transgenic; Neoplasm Metastasis; Neoplasms, Experimental; Oncolytic Virotherapy; Receptors, Laminin; Sindbis Virus; Tetradecanoylphorbol Acetate | 2012 |
Tumor-promoting activity of 2,3-dihydrophorbol myristate acetate and phorbolol myristate acetate in mouse skin.
Topics: Animals; Dermatitis, Contact; Female; Mice; Mice, Inbred ICR; Neoplasms, Experimental; Papilloma; Phorbols; Skin Neoplasms; Structure-Activity Relationship; Tetradecanoylphorbol Acetate | 1978 |